Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lopain (MTX-071) in chronic osteoarthritic knee pain
NCT02566564Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Lopain in osteoarthritis (OA), sponsored by Grünenthal GmbH. Primary endpoint: Intensity and severity of AES/SAEs potentially causally related with the study medication up to 6 months. Started Apr 2016; status: completed.
02
Drugs
Lopain
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02566564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02566564.